Publication:
The CD34-microvascular density in colorectal cancer patients

Simple item page
dc.contributor.authorBalac, I. (55190020400)
dc.contributor.authorJurisic, Vladimir (6603015144)
dc.contributor.authorLaban, A. (55189150900)
dc.contributor.authorRandelovic, T. (23499133300)
dc.contributor.authorKnezevic, P. (55189227600)
dc.contributor.authorPantic, I. (36703123600)
dc.contributor.authorDzodic, R. (6602410321)
dc.date.accessioned2025-07-02T12:40:54Z
dc.date.available2025-07-02T12:40:54Z
dc.date.issued2012
dc.description.abstractPurpose: To investigate the influence of the angiogenesis parameter CD34 microvascular density (MVD) on overall survival of colorectal cancer (CRC) patients. Methods: Thirty-one CRC patients were followed-up for 72 months after curative colorectal operation. Blood vessels measurement was done using the CD34-MVD immunochemistry method, and light microscopy. Results: MVD was inversely correlated with patients' survival. MVD value < 35 proved as independent good prognostic factor, and patients with this value lived during the 72-month follow up after surgery, while a MVD value > 65 was an independent poor prognostic factor and such patients died within 11 months after radical surgery for CRC (p<0.01). Conclusion: According to these results, the CD34-MVD seems to be a significant prognosticator of overall survival in CRC patients. © 2012 Zerbinis Medical Publications.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84859813436&partnerID=40&md5=ac5fe72914fb9524eb5470d8339aa96b
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/13997
dc.subjectAngiogenesis
dc.subjectCD34
dc.subjectColorectal cancer
dc.subjectMicrovascular density
dc.subjectSurvival
dc.titleThe CD34-microvascular density in colorectal cancer patients
dspace.entity.typePublication

Files

Collections

Publikacije / Publications